Clinical Trials Logo

Thyroid Cancer clinical trials

View clinical trials related to Thyroid Cancer.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06269731 Not yet recruiting - Thyroid Cancer Clinical Trials

Anxiety & Depression in Thyroid Cancer Patients

Start date: March 2024
Phase:
Study type: Observational

1. To identify the prevalence of both anxiety and depression in thyroid cancer patients 2. To assess quality of life in thyroid cancer patients

NCT ID: NCT06261190 Not yet recruiting - Thyroid Cancer Clinical Trials

Active Surveillance for Low-risk Papillary Thyroid Carcinoma

MAeSTro?
Start date: March 4, 2024
Phase:
Study type: Observational

This study is an observational cohort study targeting patients with low-risk Papillary thyroid cancer who opted for active surveillance or immediate surgery based on a sufficient understanding of the treatment options. The primary objective of the study is to evaluate progression free survival of the patients with low-risk Papillary thyroid cancer who choose active surveillance, in other words, to observe the natural course of low-risk Papillary thyroid cancer.

NCT ID: NCT06239194 Not yet recruiting - Breast Cancer Clinical Trials

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

Start date: May 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This study is designed to characterize the safety, tolerability, and anti-tumor activity of MDX2001 in patients with advanced solid tumors.

NCT ID: NCT06220656 Not yet recruiting - Thyroid Cancer Clinical Trials

TRAIL Study: Feasibility and Pilot

Start date: March 2024
Phase: N/A
Study type: Interventional

This is a pilot study to compare two ways of managing newly identified thyroid nodules that are likely to be cancerous based on ultrasound result and which under usual care would undergo immediate biopsy. The main goals of this pilot study are 1) compare anxiety at 6 months in each treatment arm using the validated instrument Anxiety-CA, 2) measure thyroid quality of life in each treatment arm Participants will be randomized to one of two groups: 1. immediate biopsy (usual care) 2. Active monitoring (serial ultrasound based monitoring and close clinical follow-up)

NCT ID: NCT06146985 Not yet recruiting - Thyroid Cancer Clinical Trials

Famitinib in Combination With Adebrelimab for the Treatment of Advanced Thyroid Cancer

Start date: December 1, 2023
Phase: Phase 2
Study type: Interventional

This is a multi-cohort, open-label, single-centre, Phase 2 study aiming to investigate the efficacy and safety of a regimen using the multi-targeted kinase inhibitor Famitinib in combination with the PD-L1 antibody Adebrelimab for the patients with unresectable locally advanced or metastatic refractory to standard treatment differentiated thyroid cancer (DTC), medullary thyroid carcinoma (MTC) as well as Anaplastic thyroid carcinoma (ATC).

NCT ID: NCT06134830 Not yet recruiting - Thyroid Cancer Clinical Trials

Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.

Start date: March 1, 2024
Phase:
Study type: Observational

1. Determine the frequency of utilizing single and multiple doses of radioactive iodine (RAI) in treatment of differentiated thyroid cancer. 2. Asses the impact of various doses of radioactive iodine on the management of differentiated thyroid cancer. 3. Investigate the influence of thyroid cancer on the quality of life of affected patients.

NCT ID: NCT06101043 Not yet recruiting - Thyroid Cancer Clinical Trials

PECS II Block and Single Port Robot-assisted Transaxillary Thyroidectomy

Start date: January 4, 2024
Phase: N/A
Study type: Interventional

The da Vinci robotic system was developed to improve both operative maneuverability (through multi-articulated instruments) and the surgical view (via a three-dimensional camera). Although the system has many advantages, skin incision, wide flap dissection, and pneumatic/mechanical retraction remain essential, but cause postoperative pain and slower recovery. Previous studies found that pectoralis fascial blocks were easy to establish; local anesthetics are injected between two adjacent myofascial layers under ultrasound guidance, providing the surgeon with a clear image. Analgesic efficacy has been validated during robotic thyroidectomy in our institution. The pain outcomes were comparable between the groups, but there were fewer complications in the PECS II group. The investigators investigated whether this block can reduce postoperative pain during wide flap dissection for single-port robot-assisted transaxillary thyroidectomy.

NCT ID: NCT05758025 Not yet recruiting - Thyroid Cancer Clinical Trials

A New Surgical Strategy to Protect the Inferior Parathyroid

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

The incidence of temporary hypoparathyroidism after thyroid surgery is 14%-60%, and the incidence of permanent hypoparathyroidism is 4%-11%. The protection of parathyroids has always been the focus and difficulty of thyroid surgery. The anatomical position of the superior parathyroids is relatively fixed, and can be preserved in situ easily; while the anatomical position of inferior parathyroids varies greatly between patients. It is always difficult to look for, identify, and protect them. Concepts such as thyro-thymic ligament and "thymus-vascular-inferior parathyroid plane" were raised to help identify the inferior parathyroids. We found that this surgical strategy can protect inferior parathyroids in situ effectively in our retrospective studies. Thus, we are going to carry out a prospective study to compare the new method and the traditional method of thyroidectomy, to see if more inferior parathyroids can be protected in situ through the new surgical strategy.

NCT ID: NCT05468554 Not yet recruiting - Thyroid Cancer Clinical Trials

Evaluation of Metformin Effect on the Fertility of Women Treated With 131I for Thyroid Cancer

METHYR
Start date: November 1, 2022
Phase: Phase 3
Study type: Interventional

This study is aimed to investigate the metformin effect on the fertility of women treated with 131 I for thyroid cancer

NCT ID: NCT05446441 Not yet recruiting - Thyroid Cancer Clinical Trials

Endoscopic Thyroidectomy Versus Open Thyroidectomy for Papillary Thyroid Carcinoma

Start date: June 28, 2022
Phase: N/A
Study type: Interventional

Recently, endoscopic thyroidectomy using gasless unilateral transaxillary approach has been proven feasible and safe in several Chinese medical centers. This study is aimed to compare multi-institutional Chinese outcomes of endoscopic thyroidectomy using gasless unilateral transaxillary approach and conventional open surgery.